SCHEMBL20037590

SCHEMBL20037590

Nc1ccc(N2CCN(C=O)CC2=O)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 2/20 0.35
DRD3 P35462 1/20 0.33
KCNH2 Q12809 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRNA4 P43681 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GCK P35557 2/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
ATM Q13315 1/20 0.32
ALOX5AP P20292 2/20 0.31
FEN1 P39748 2/20 0.31
TRPC6 Q9Y210 1/20 0.31
PIK3R1 P27986 1/20 0.31
PIK3CA P42336 1/20 0.31
GCKR Q14397 2/20 0.31
AKR1C3 P42330 1/20 0.30
MAOB P27338 1/20 0.30
NTRK1 P04629 1/20 0.30
GABRP O00591 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18291377 0.84 DRD3 (0.48) DRD3KCNH2CHRNB2CHRNA4ALDH1A1
SCHEMBL20037981 0.84 DRD3 (0.33) DRD3KCNH2ALDH1A1GAAATM
SCHEMBL20249159 0.81 DRD3 (0.33) DRD3KCNH2AKR1C3
SCHEMBL24179944 0.80 MAPT (0.50) DRD3KCNH2CHRNB2CHRNA4SMN1; SMN2
SCHEMBL2820372 0.79 SLC6A2 (0.44) MTORDRD3KCNH2CHRNB2CHRNA4
SCHEMBL22813083 0.78 TRPC6 (0.42) MTORCHRNB2CHRNA4KDM4EGCK
SCHEMBL1393916 0.75 GABRP (0.39) KCNH2CHRNB2CHRNA4KDM4EALDH1A1
SCHEMBL29813620 0.75 GAA (0.40) MTORDRD3KCNH2KDM4EALDH1A1
SCHEMBL24525802 0.75 GAA (0.40) MTORDRD3KCNH2KDM4EALDH1A1
SCHEMBL17055336 0.75 HRH3 (0.39) MTORDRD3KCNH2CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed